Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease

Détails

ID Serval
serval:BIB_70C0094C7AA3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease
Périodique
JPEN: Journal of Parenteral and Enteral Nutrition
Auteur⸱e⸱s
Morin  C. L., Roulet  M., Roy  C. C., Weber  A., Lapointe  N.
ISSN
0148-6071 (Print)
Statut éditorial
Publié
Date de publication
06/1982
Volume
6
Numéro
3
Pages
194-9
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: May-Jun
Résumé
Ten pediatric patients, aged 8.5-19 years, with active symptomatic Crohn's disease, received a three-week period of continuous elemental enteral alimentation with no other form of treatment. All patients in this study were selected according to the following criteria, which were applied consecutively: (1) newly diagnosed patients with no previous treatment for Crohn's disease, (2) disease activity index over 200, and (3) no complication requiring surgery. All patients experienced a clinical remission and improved their immunologic and nutritional status during the elemental enteral alimentation. The mean disease activity index for the whole group was 307.0 +/- 23.6 (range: 203 to 413) before and 69.2 +/- 11.4 (range: 15 to 114) after the feeding period. Significant increases in body weight, triceps skinfold, mid-arm circumference, serum transferrin and mean percentage of T lymphocytes were also observed. Following cessation of enteral alimentation, a small declining dose of prednisone was used during a one-year follow-up period. Eight of the ten patients were still in clinical remission three months after the feeding period and their nutritional status had continued to improve during that period of time.
Mots-clé
Adolescent Adult Body Weight Child Crohn Disease/*therapy *Enteral Nutrition Female *Food, Formulated Humans Leukocyte Count Male Prednisone/therapeutic use Skinfold Thickness T-Lymphocytes Time Factors Transferrin/analysis
Pubmed
Web of science
Création de la notice
24/01/2008 20:33
Dernière modification de la notice
20/08/2019 14:29
Données d'usage